AlphaCentric Advisors’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Hold
600,000
1.1% 16
2025
Q4
$1.38M Buy
+600,000
New +$1.6M 1.38% 11
2024
Q4
$1.37M Hold
600,000
1.37% 19
2024
Q3
$1.22M Hold
600,000
0.91% 36
2024
Q2
$1.09M Hold
600,000
0.8% 43
2024
Q1
$1.57M Hold
600,000
0.94% 34
2023
Q4
$1.05M Hold
600,000
0.7% 55
2023
Q3
$948K Buy
600,000
+50,000
+9% +$80K 0.54% 67
2023
Q2
$842K Hold
550,000
0.47% 76
2023
Q1
$1.12M Buy
550,000
+50,000
+10% +$112K 0.77% 40
2022
Q4
$1.03M Hold
500,000
1.02% 35
2022
Q3
$900K Buy
+500,000
New +$1.07M 0.92% 30
2021
Q4
$2.33M Buy
375,000
+25,000
+7% +$149K 0.68% 7
2021
Q3
$1.88M Buy
350,000
+25,000
+8% +$188K 0.48% 7
2021
Q2
$3.13M Hold
325,000
0.85% 5
2021
Q1
$2.18M Hold
325,000
0.74% 5
2020
Q4
$1.65M Buy
325,000
+25,000
+8% +$102K 0.69% 7
2020
Q3
$1.07M Buy
300,000
+50,000
+20% +$193K 0.52% 8
2020
Q2
$1.11M Buy
+250,000
New +$1.01M 0.63% 8

Other funds holding STXS

AlphaCentric Advisors's STXS Position: Q1 2026 in Review

AlphaCentric Advisors held its Stereotaxis (STXS) position steady in Q1 2026 at 600,000 shares worth $1.1M. The position accounts for 1.1% of the portfolio, ranked #16.

AlphaCentric Advisors first reported a position in STXS in Q2 2020 and has held it in 19 quarters since. The position peaked at $3.13M in Q2 2021. 115 funds tracked by Wall St. Rank hold STXS as of Q1 2026.

  • AlphaCentric Advisors held 600,000 shares of Stereotaxis worth $1.1M as of Q1 2026.
  • AlphaCentric Advisors left its Stereotaxis share count unchanged in Q1 2026.
  • Stereotaxis made up 1.1% of AlphaCentric Advisors's portfolio in Q1 2026, its #16 holding.
  • AlphaCentric Advisors first reported a position in Stereotaxis in Q2 2020 and has held it in 19 quarters since.
  • AlphaCentric Advisors's Stereotaxis position peaked at $3.13M in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.